See more : Global Indemnity Limited SUB NT 47 (GBLIL) Income Statement Analysis – Financial Results
Complete financial analysis of Ishita Drugs and Industries Limited (ISHITADR.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ishita Drugs and Industries Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- AudioCodes Ltd. (AUDC.TA) Income Statement Analysis – Financial Results
- Hokuetsu Industries Co., Ltd. (6364.T) Income Statement Analysis – Financial Results
- coconala Inc. (4176.T) Income Statement Analysis – Financial Results
- Hopium SA (ALHPI.PA) Income Statement Analysis – Financial Results
- Companhia Paranaense de Energia – COPEL (XCOP.MC) Income Statement Analysis – Financial Results
Ishita Drugs and Industries Limited (ISHITADR.BO)
About Ishita Drugs and Industries Limited
Ishita Drugs & Industries Ltd. engages in the manufacturing of basic drugs. It offers active pharma ingredients, drug intermediates, fine chemicals, and finished dosage forms. The company was founded by Jagdishprasad Gokulchand Agrawal on February 5, 1992 and is headquartered in Ahmedabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 151.88M | 120.72M | 140.90M | 139.49M | 148.32M | 90.87M | 67.74M | 58.39M | 65.40M | 69.69M | 73.36M | 117.63M | 51.91M | 88.29M | 63.93M | 49.60M | 40.47M |
| Cost of Revenue | 126.13M | 89.85M | 107.15M | 109.04M | 120.93M | 70.03M | 51.03M | 42.95M | 52.78M | 55.27M | 57.47M | 100.88M | 36.38M | 61.96M | 45.79M | 31.94M | 23.75M |
| Gross Profit | 25.75M | 30.87M | 33.76M | 30.45M | 27.39M | 20.84M | 16.71M | 15.44M | 12.63M | 14.42M | 15.89M | 16.76M | 15.54M | 26.33M | 18.14M | 17.67M | 16.72M |
| Gross Profit Ratio | 16.95% | 25.57% | 23.96% | 21.83% | 18.47% | 22.93% | 24.67% | 26.45% | 19.31% | 20.69% | 21.66% | 14.25% | 29.93% | 29.83% | 28.37% | 35.62% | 41.32% |
| Research & Development | 178.12K | 164.70K | 169.97K | 156.90K | 140.30K | 164.45K | 146.79K | 189.41K | 176.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.56M | 3.73M | 4.96M | 3.85M | 3.15M | 2.43M | 1.78M | 2.09M | 1.58M | 1.93M | 3.91M | 3.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 4.53M | 2.89M | 3.05M | 3.50M | 2.23M | 1.72M | 782.09K | 1.17M | 724.84K | 1.45M | 1.59M | 3.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 17.60M | 6.62M | 8.01M | 7.35M | 5.38M | 4.15M | 2.56M | 3.26M | 2.30M | 3.38M | 5.50M | 6.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 2.01M | 1.06M | 3.14M | 1.62M | 0.00 | 0.00 | 0.00 | -923.51K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 34.75M | 24.55M | 24.14M | 22.74M | 21.54M | 17.24M | 13.54M | 13.63M | 11.50M | 12.74M | 12.74M | 12.25M | 12.16M | 20.26M | 12.73M | 14.12M | 12.99M |
| Cost & Expenses | 143.91M | 114.40M | 131.29M | 131.77M | 142.46M | 87.27M | 64.57M | 56.57M | 64.28M | 68.01M | 70.21M | 113.13M | 48.54M | 82.22M | 58.52M | 46.05M | 36.74M |
| Interest Income | 1.81M | 1.43M | 682.27K | 403.12K | 455.69K | 692.45K | 426.04K | 1.20M | 898.49K | 643.61K | 651.33K | 804.24K | 0.00 | -145.00K | 930.28K | 673.84K | 0.00 |
| Interest Expense | 898.00K | 365.00K | 42.94K | 185.32K | 211.58K | 494.72K | 937.97K | 162.27K | 160.00K | 195.31K | 200.36K | 132.47K | 0.00 | 62.00K | 128.00K | 122.00K | 131.00K |
| Depreciation & Amortization | 1.12M | 1.29M | 1.30M | 1.46M | 1.77M | 1.56M | 1.36M | 1.40M | 1.54M | 1.53M | 1.16M | 924.91K | 783.00K | 743.00K | 1.87M | 2.50M | 2.46M |
| EBITDA | 11.89M | 9.62M | 11.97M | 12.32M | 9.26M | 6.79M | 5.72M | 4.42M | 4.02M | 4.83M | 4.52M | 4.60M | 4.16M | 6.83M | 7.30M | 5.99M | 6.19M |
| EBITDA Ratio | 7.83% | 7.83% | 8.35% | 8.73% | 6.15% | 7.35% | 8.16% | 7.08% | 5.55% | 6.61% | 5.34% | 3.91% | 8.02% | 7.74% | 11.42% | 12.08% | 15.29% |
| Operating Income | 7.97M | 6.32M | 9.61M | 7.72M | 5.86M | 3.60M | 2.60M | 2.21M | 1.21M | 3.08M | 2.76M | 3.67M | 3.38M | 6.09M | 5.43M | 3.49M | 3.74M |
| Operating Income Ratio | 5.25% | 5.24% | 6.82% | 5.53% | 3.95% | 3.96% | 3.83% | 3.78% | 1.85% | 4.42% | 3.76% | 3.12% | 6.51% | 6.90% | 8.50% | 7.03% | 9.23% |
| Total Other Income/Expenses | 1.90M | 1.47M | 815.72K | 2.82M | 1.28M | 1.03M | 66.74K | 755.91K | 802.08K | -195.31K | -100.18K | 2.44M | -284.00K | -224.00K | -127.00K | 478.82K | -131.00K |
| Income Before Tax | 9.87M | 7.79M | 10.43M | 10.54M | 7.13M | 4.63M | 3.23M | 2.57M | 1.93M | 2.88M | 3.05M | 6.11M | 3.09M | 5.85M | 5.28M | 3.97M | 3.60M |
| Income Before Tax Ratio | 6.50% | 6.46% | 7.40% | 7.55% | 4.81% | 5.09% | 4.77% | 4.40% | 2.94% | 4.14% | 4.15% | 5.19% | 5.96% | 6.62% | 8.26% | 8.00% | 8.90% |
| Income Tax Expense | 2.39M | 2.02M | 2.38M | 2.24M | 1.66M | 1.11M | 753.89K | 745.51K | 553.72K | 666.88K | 1.00M | 1.93M | 1.02M | 1.96M | 1.42M | -9.31K | -522.00K |
| Net Income | 7.49M | 5.77M | 8.05M | 8.30M | 5.47M | 3.52M | 2.48M | 1.82M | 1.37M | 2.22M | 2.04M | 4.18M | 2.08M | 3.89M | 4.16M | 3.98M | 2.47M |
| Net Income Ratio | 4.93% | 4.78% | 5.71% | 5.95% | 3.69% | 3.87% | 3.66% | 3.12% | 2.10% | 3.18% | 2.78% | 3.55% | 4.00% | 4.40% | 6.51% | 8.02% | 6.10% |
| EPS | 2.50 | 1.93 | 2.69 | 2.77 | 1.83 | 1.18 | 0.83 | 0.61 | 0.46 | 0.74 | 0.68 | 1.40 | 0.69 | 1.31 | 1.29 | 1.33 | 1.38 |
| EPS Diluted | 2.50 | 1.93 | 2.69 | 2.77 | 1.83 | 1.18 | 0.83 | 0.61 | 0.46 | 0.74 | 0.68 | 1.40 | 0.69 | 1.31 | 1.29 | 1.33 | 1.38 |
| Weighted Avg Shares Out | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 3.01M | 2.97M | 3.23M | 2.99M | 1.79M |
| Weighted Avg Shares Out (Dil) | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 2.99M | 3.01M | 2.97M | 3.23M | 2.99M | 1.79M |
No news found for: ISHITADR.BO
Source: https://incomestatements.info
Category: Stock Reports